Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Touw, C.M.; Smit, G.P.; Niezen-Koning, K.E.; Bosgraaf-de Boer, C.; Gerding, A.; Reijngoud, D.J.; Derks, T.G.
    In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes (2013), Orphanet J. Rare Dis., 8, 43 .
    View publication on PubMedView publication on EuropePMC

Application

EC Number Application Comment Organism
1.3.8.7 medicine analysis of variant enzymes identified in newborns. Enzyme analyses with hexanoyl-CoA, hexanoyl-CoA + butanoyl-CoA, and phenylpropionyl-CoA show significantly higher residual medium-chain acyl-CoA dehydrogenase activities in subjects with variant ACADM genotypes when compared to patients with classical ACADM genotypes. After prolonged fasting no hypoglycaemia is observed. Increasing concentrations of free fatty acids indicate lipolysis, and ketone body concentrations are sufficient for blood glucose concentrations in 5 out of 6 subjects. Phenylpropionic acid loading demonstrates in vivo residual enzyme activity in all studied subjects Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
1.3.8.7 Homo sapiens
-
-
-

Synonyms

EC Number Synonyms Comment Organism
1.3.8.7 ACADM
-
Homo sapiens